|
|
|
|
|
by adw
1995 days ago
|
|
You'd probably be interested in https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9... This paper points out that patients on infliximab (trade name Remicade: immune system modulator used by people with chronic autoimmune diseases, particularly IBD and rheumatoid arthritis) don't seem to be at elevated risk of severe COVID – which is surprising because these are powerful immune system suppressants. |
|